Funding of $2.7 million was raised by GlucoVista, an Israeli medical device company.
The new capital will be used by the company to fund its glucose monitoring wristband for Type 1 and Type 2 diabetes patients.
GlucoVista’s R&D team, based in Israel, consists of a seasoned group of scientists and engineers with extensive and unique experience working in electro-optics and in the IR spectrum and in developing commercially viable consumer products.
